MetaVia Reports Preclinical DA-1726 Weight-Loss Data
MetaVia said preclinical results showed DA-1726 achieved weight loss comparable to retatrutide with less food-intake suppression.
MetaVia said preclinical results showed DA-1726 achieved weight loss comparable to retatrutide with less food-intake suppression.